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1. Introduction
The calcium-binding protein apoaequorin, endogenous to the 
luminescent jellyfish Aequorea victoria, has been used for over 
40 years as a research molecule in studies of intracellular physi-
ology of the calcium ion. This small protein (22.3 kDa) possesses 
three calcium-binding sites of the EF-hand motif and belongs to 
the superfamily of calcium-binding proteins that facilitate sig-
nal transduction, gene transcription, enzyme activation, intra-
cellular calcium buffering and in the case of conjugated form of 
apoaequorin, aequorin, and related proteins, bioluminescence 
(Deng et al., 2004, Heizmann, 1992, Deng et al., 2005 and Yáñez 
et al., 2012). When the apo-form of the protein is conjugated to 
its prosthetic group, coelenterazine, the resulting molecule, ae-
quorin, luminesces upon binding the calcium ion in vivo or in vi-
tro (Kendall and Badminton, 1998). Properly stimulated, cells con-
taining aequorin release light showing where, when and how 
much free, cytosolic calcium ion is released from internal stores 
or across the cell membrane in response to stimuli (Snowdowne 
et al., 1984). This photoprotein has been used for in vitro and in 
vivo studies as an indicator molecule for understanding calci-
um’s role in signal transduction, metabolism, development, and 
particularly, brain cell physiology (Grienberger and Konnerth, 
2012 and Kendall and Badminton, 1998). Some calcium-bind-
ing proteins coordinate the role of the calcium ion in the cell; 
maintaining calcium homeostasis within finely tuned concentra-
tion limits to avoid toxicity while preserving calcium’s influence 
on cell physiology.
Because of its unique commercial value, a large-scale manufac-
turing process has been developed to produce kilogram quanti-
ties of this protein for use in a number of applications pertinent to 
human health and well-being. The potential increased exposure of 
human and animal populations to this protein required a toxico-
logical and allergenic analysis from regulatory agencies and indus-
trial best-practice standards. An extensive 90-day subchronic tox-
icology study was performed in Sprague–Dawley rats to test the 
oral route of delivery of the purified protein (Moran et al., 2013). 
There were no clinical pathology or histopathological changes in 
the animals receiving the protein and any changes of note were 
typical of those historically observed changes in the age and strain 
of rats used in the study. A No Observed-Adverse-Effect Level 
(NOAEL) for apoaequorin was determined at 2000× (expected hu-
man exposure) and an ADI safety margin of 666.7 mg/kg bwt/day 
was established, which was the highest dose tested.
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Abstract
Calcium-binding proteins are ubiquitous modulators of cellular activity and function. Cells possess numerous calcium-bind-
ing proteins that regulate calcium concentration in the cytosol by buffering excess free calcium ion. Disturbances in intra-
cellular calcium homeostasis are at the heart of many age-related conditions making these proteins targets for therapeu-
tic intervention. A calcium-binding protein, apoaequorin, has shown potential utility in a broad spectrum of applications for 
human health and well-being. Large-scale recombinant production of the protein has been successful; enabling further re-
search and development and commercialization efforts. Previous work reported a 90-day subchronic toxicity test that dem-
onstrated this protein has no toxicity by oral exposure in Sprague–Dawley rodents. The current study assesses the allergenic 
potential of the purified protein using bioinformatic analysis and simulated gastric digestion. The results from the bioinfor-
matics searches with the apoaequorin sequence show the protein is not a known allergen and not likely to cross-react with 
known allergens. Apoaequorin is easily digested by pepsin, a characteristic commonly exhibited by many non-allergenic di-
etary proteins. From these data, there is no added concern of safety due to unusual stability of the protein by ingestion.
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The current study continues the risk assessment of the pro-
tein through bioinformatic and simulated gastric digestion tests 
to evaluate the potential allergenicity of this protein. Character-
ization of the expressed protein included N-terminal sequencing, 
molecular weight determination, and luminescent activity, which 
verified the identity and functionality of the protein. With the ex-
pected post-translational processing and the fidelity of the ge-
netic expression construction confirmed, an allergenic risk as-
sessment was performed. This included a protein sequencing 
analysis in an exhaustive bioinformatic assessment against al-
lergen databases and an in vitro simulated gastric digestion of 
the protein. These approaches have proven invaluable as tools 
in assessing the potential allergenicity of genetically engineered 
proteins since they consider the primary amino acid sequence 
of known allergenic proteins that could pose a risk of allergy to 
those sensitized by other exposure and in evaluating the likeli-
hood the novel protein might pose a high risk of sensitization 
or elicitation upon ingestion. Although the tests cannot prove an 
absence of risk of allergy, they have been deemed highly predic-
tive of a protein’s allergenic potential.
In vitro digestion in pepsin was performed to determine the 
level of resistance to protease cleavage under optimum pH con-
ditions. Investigation of proteins that have been tested in this 
way suggest a strong positive predictive value that food aller-
gens causing systemic reactions are relatively stable in the as-
say, while non-allergenic food proteins are typically digested 
relatively quickly (Bannon et al., 2002). Astwood et al. (1996) pub-
lished the first use of in vitro pepsin digestion as an assay show-
ing that many food allergens or protein fragments were resistant 
to digestion. Thomas et al. (2004) published a method standard-
izing the pH, purity of the protease, ratio of pepsin to test article, 
and purity of the test protein. We (Ofori-Anti et al., 2008) added 
an objective measure of the degree of digestion to improve the 
evaluation for assessing digestibility. However, although a corre-
lation exists between allergenicity of dietary proteins and pep-
sin resistance (Astwood et al., 1996) some unstable allergens 
may be protected in the food matrix of the gut in vivo (Polovic et 
al., 2007). Since no single determinant has been found to be full 
proof for predicting allergenicity, international consensus has es-
tablished a weight-of-evidence approach in assessing allergenic 
potential of new proteins (Codex, 2003).
2. Method and materials
2.1. Strain development
A synthetic gene for the protein sequence P02592 (UniProtKB/
Swiss-Prot) was codon-optimized for expression in a prokaryotic 
cell line. The synthetic gene (Life Technologies) was subcloned 
into an expression cassette following standard molecular proto-
cols for site-specific integration into the host strain, Escherichia coli 
BL21(DE3), and targeted secretion to the fermentation medium. 
Genomic insertion of the gene was performed by the homolo-
gous recombination method of Hamilton et al. (1989) with varia-
tions needed to target a non-essential operon of the host strain. 
Clones carrying only the expression cassette minus vector DNA 
were isolated using PCR for both the gene of interest and the an-
tibiotic resistance gene. Isolated clones were verified by Southern 
blot analysis using radiolabeled probes of the antibiotic and gene 
of interest sequences (data not shown). A single clone was devel-
oped for industrial production of the protein and was named QB6.
The fidelity of the genomic insertion sequence was verified 
by DNA sequencing through PCR amplification using the primer 
pairs specific to the coding region; CAG TAT AGC GTC AAA CTG 
as the forward primer and TGG TGC TCG ACT TAT TAC for the re-
verse primer. A single band of the PCR product was visualized 
by agarose gel electrophoresis. The band was excised from the 
gel and was sequenced analysis in both directions (ACGT, Inc., 
Wheeling, IL).
2.2. Protein production and purification
Fermentation of the strain was performed by large-scale produc-
tion processes and successfully produced multi-gram quantities of 
the secreted protein using lactose induction in a proprietary me-
dium formulation. Clarification of the resulting fermentation broth 
by tangential flow filtration was followed by large-scale ion ex-
change chromatography. This resulted in a solution of the protein 
that was 90% pure. Acid precipitation with 10% acetic acid to a pH 
of 4.2 was followed by centrifugation at 2500g for 30 min. The su-
pernatant was poured off, which aided in the removal of UV ab-
sorbing contaminants, leaving concentrated protein as the pel-
let. Resuspension of the protein (25 mM TRIS, 25 mM NaCl and 
1 mM EDTA, pH 8.5) followed by gel filtration chromatography re-
moved residual salts and contaminants. Pooled fractions from gel 
filtration were concentrated through tangential flow filtration us-
ing membranes of a nominal molecular weight cutoff of 5 kDa to 
obtain an approximate concentration of 20 mg/mL solution as de-
termined by absorbance at 280 nm (A280) and a theoretical ex-
tinction coefficient for the apoprotein of 2.0. The protein was ster-
ile filtered and kept frozen at −20 °C in buffer (25 mM TRIS, and 
25 mM NaCl, pH 7.6), until use.
2.3. Protein characterization
N-terminal sequence of the first 30 amino acids of the recombi-
nantly expressed apoaequorin was determined from samples puri-
fied from culture medium by SDS–PAGE and electroblotted onto a 
PVDF membrane. The protein bands were visualized by Ponseau S 
staining and N-terminal sequencing was completed at the Medical 
College of Wisconsin Protein and Nucleic Acid Facility.
The protein was further characterized by SDS PAGE (Novex Bis-
Tris 4–12% gradient gels following the manufacturer’s instructions 
– Life Technologies). The gel was stained with a commercial prepa-
ration of coomassie brilliant blue solution (Thermo Fisher Imperial 
Protein Stain) and destained overnight in distilled water. The de-
stained gels were visualized in a Kodak Gel Logic 440 Image Sta-
tion under white light transillumination. The image was captured 
and purity was estimated by densitometric analysis of the stained 
gel. This estimate was used in digestion studies of the protein.
Enzymatic activity of the protein was determined by regener-
ating the holoprotein, aequorin, and demonstrating calcium-bind-
ing activity through the chemiluminescence of the protein. Meth-
ods for the regeneration, luminescent activity, and measurements 
of photons followed Shimomura (1991) with minor modifications. 
Briefly, the assay was miniaturized for use in white, 96-well microti-
ter plate format to measure luminescence. Bioluminescence was 
measured on a Biotek luminometer plate reader controlled by the 
KC4 software (Biotek). Samples were discharged to produce blue 
light (462 nm) by the addition of 300 μL of assay buffer (20 mM 
calcium acetate in 10 mM TRIS, pH 7.6). Photons were collected 
over a three-second time period and maximum luminosities were 
averaged by the software for each dilution of each sample. The av-
erage relative luminous units were calculated for each sample. The 
results from eight dilutions were averaged for each sample and 
these data were validated by comparative analysis against the pro-
tein’s kinetic accumulation during fermentation.
2.4. Allergenicity testing: Sequence search in silico
Potential allergy and cross-reactivity risk assessment was per-
formed using methods typically used for food-safety evaluation as 
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prescribed by the Codex Alimentarius Guidelines (2003). The bio-
informatics study was designed to compare the protein sequence 
of apoaequorin with those of known allergens in 2010 with ver-
sion 10 of the AllergenOnline.org database (AOL v10) maintained 
by the Food Allergy Research and Resource Program (FARRP) at 
the University of Nebraska. This was repeated with version 13 
of AllergenOnline.org on 5 December 2013 along with BLASTP 
searches of NCBI Protein database to evaluate possible matches to 
newly discovered allergens. The purpose of the search was to de-
termine whether the protein could be identified as a known aller-
gen (~95–100% match to an allergen listed in AllergenOnline.org), 
or was sufficiently similar to a known allergen (>35% identity over 
any segment of 80 amino acids) to suspect potential allergic cross-
reactivity. The first search was performed using the FASTA3 algo-
rithm (Pearson, 2000) with the default scoring matrix (BLOSUM 50) 
to evaluate overall alignment of each query sequence compared 
to all sequences in AllergenOnline, looking for matches of low E-
score values (<1e-7) and greater than 50% identity as likely signifi-
cant scores suggesting potential cross-reactivity.
Additionally, an 80-amino acid sliding window identity search 
was performed that systematically tests all possible 80-amino acid 
segments of apoaequorin with >35% identity to any known or pu-
tative allergen listed in the AOL database, using the same FASTA3 
algorithm. Significant matches identified by either search would 
suggest a need to perform human serum testing using sera from 
specifically allergic donors to evaluate for potential IgE cross-reac-
tivity (Codex, 2003).
Additional information considered in this study included a 
search of the protein sequence for any eight contiguous amino acid 
matches (8mer) to any known allergen in AOL. This step is required 
by some international regulatory agencies however, it has not been 
demonstrated to have a substantial predictive value for allergenicity. 
This step was included to meet our regulatory purposes.
The protein sequence was also searched against the non-re-
dundant NCBI dataset using BLASTP with default values for 
BLOSUM 62 to evaluate homologs of the query protein to under-
stand protein function and further screen for potential safety is-
sues. This protein is in the family of Ca+2 binding proteins and is 
most closely related to similar proteins from other hydrozoans of 
the phylum Cnidaria with E-scores smaller than 10−40 and identi-
ties of >60% over the full-length. Additionally, a BLASTP search 
using the keyword limit of “allerg*” to any “keyword” allergen se-
quence in NCBI with an E-score smaller than 10−3 or a sequence 
homology of >35% identity was performed.
References in the PubMed database were also searched using 
the organism name (A. victoria) as well as family name (Aequore-
idae) and the keyword “allerg*” to learn whether there is informa-
tion to indicate whether the source organism is a common cause 
of allergy.
2.5. Simulated gastric digestion
The pepsin stability assay is one study in a “weight of evidence 
approach” intended to assess the potential allergenicity of genet-
ically modified crops (Codex, 2003). The assay described by Ast-
wood et al. (1996) was refined further; adding an objective mea-
surement of the extent of digestion as described by Ofori-Anti et 
al. (2008). The assay was performed under standard conditions of 
10 units of pepsin activity per microgram of test protein using a 
high purity form of pepsin from Worthington Biochemical, Corp., 
The mass ratio was approximately 3.6 mg pepsin per mg of test 
protein and other quality control measures as recommended by 
Ofori-Anti et al. (2008) were followed.
The original assay described by Astwood et al. (1996) recom-
mends performing the digestion at pH 1.2. However, the FAO/
WHO (2001) recommends using two pH conditions (pH 1.2 and pH 
2.0). Two independent assays were conducted at each pH in this 
study. The assay was performed at 37 °C and samples removed at 
specific times and the activity of pepsin quenched by neutraliza-
tion with carbonate buffer and Laemmli loading buffer. Samples 
were then heated to more than 70 °C for 5 min and frozen until 
analyzed by SDS–PAGE. The timed digestion samples were sepa-
rated by SDS–PAGE (Novex 10–20% tris–glycine gels following the 
manufacturer’s instructions – Life Technologies) fixed, and stained 
with coomassie or colloidal blue to evaluate the extent of diges-
tion. All samples on each gel were from a single digestion experi-
ment. The samples were heat to 95 °C, cooled and 10 μL each were 
loaded per well (1.47 μg protein per well). Bio-Rad Precision Plus 
molecular weight marker proteins were loaded in one outer well, 
Invitrogen Sharp Standards marker LC5800 was loaded in the op-
posite outer well. Stained gels were visualized in a Kodak Gel Logic 
440 Image Station under white light transillumination.
Based on the purity of apoaequorin by densitometry of SDS 
PAGE, the limit of detection was estimated using serial dilutions of 
samples of purified test protein. Undigested samples representing 
100% and 10% of the undigested protein were then included in 
the analytical digestion gels as reference standards.
3. Results and discussion
3.1. Verification of expression genetics
Verification of the integration of the expression construct into the 
host chromosome was determined by PCR and DNA sequencing 
of the amplified gene. The translated amino acid sequence was 
identical to the full-length, naturally occurring protein found in the 
jellyfish.
Following fermentation, the protein accumulated in the me-
dium of the broth and samples from time points during fermenta-
tion were used for protein activity assays (Figure 1) and SDS PAGE 
analysis (Figure 2). Protein accumulation and luminescent activ-
ity agreed well for each time point. The SDS–PAGE demonstrated 
complete N-terminal cleavage of the signal peptide sequence, suc-
cessful secretion of the protein into the medium, and confirmed 
the correct molecular weight of 22.3 kDa. The luminescent activ-
ity of the protein increased in accordance with the accumulation of 
the band density on the SDS–PAGE indicating production and se-
cretion of a properly folded and fully functional protein into the 
medium. Apoaequorin was purified to homogeneity and concen-
trated to 20 mg/mL.
Figure 1. Kinetic results of the fermentation of the QB6 clone show-
ing luminous activity of the charged apoaequorin (aequorin) as it in-
creased as protein accumulated in the broth of the medium. Arrows 
indicate the time points for lactose induction of the gene. MMRLU/s/
μL = maximum relative luminous units in millions of photons per sec-
ond per μL of sample.
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The first 30 residues of the protein were determined to be cor-
rect through N-terminal protein sequence analysis (Figure 3). This 
is as expected from the predicted DNA sequence of the expression 
cassette. The protein was produced and processed correctly, creat-
ing the same protein as found endogenously in the jellyfish.
3.2. In silico allergen sequence alignments
The full-length sequence of apoaequorin (196 amino acids), (Uni-
ProtKB/Swiss-Prot: P02592.1) was used to search the AllergenOn-
line.org database. No native signal peptide has been identified for 
this protein from A. victoria, according to Hamamoto et al. (2003) 
as a direct NCBI entry (2003). Results of the FASTA3 search of the 
apoaequorin against the AllergenOnline.org (version 10 and ver-
sion 13) did not identify any significant alignment with any allergen. 
Scoring results for the four best scoring alignments demonstrate 
no significant matches with any allergen (Table 1). The highest scor-
ing alignments were to a calcium-binding protein of olive pollen 
(Olea europaea) and a number of fish parvalbumin calcium-binding 
proteins. While the E-scores and identities suggest possible evolu-
tionary homology, the alignments represent less than one-third of 
the length of apoaequorin and the similarities are not sufficiently 
high to suspect shared antibody binding cross-reactivity.
The identity results from FASTA3 alignments using the sliding 
window of 80-amino acid algorithm did not identify any align-
ments of >35% identity to any entry in the AllergenOnline.org 
database (version 10 or 13). Furthermore, there were no identity 
matches of eight-contiguous amino acids between apoaequorin 
sequence and any entry in the AllergenOnline.org database.
The full-length apoaequorin was also compared to sequences 
in NCBI-Entrez using a keyword limit of “allerg*” on 20 June 
2010 and again on 5 December 2013 (Table 2). No alignments 
were identified with E scores below “1 × e 10−7”, or with identity 
matches of greater than 35% over any alignment of more than 80 
amino acids. These bioinformatics results did not identify any sig-
nificant alignments to any known allergens. In contrast, when no 
keyword limit was used, many high-scoring identity matches were 
found to other photo-proteins as homologs of apoaequorin from 
other jellyfish relatives.
A PubMed search was conducted to identify any publications 
that suggest the species (A. victoria) or other members of related 
taxa are known to be significant inducers of allergy. Keyword search 
terms included “Aequorea AND allergen/allergy”, “Aequoreidae AND 
allergen/allergy” (family) and “Cnidaria AND allergen/allergy” (phy-
lum). The search was conducted on 19 June 2010. The only two 
publications identified by species search reports a study of protein 
Figure 3. Amino acid sequence of apoaequorin (P02592). The encoded 
protein is 196 amino acids in length based on translation of the DNA 
sequence. The first 30 amino acids (underlined) of the expressed and 
purified protein were confirmed by LC–MSMS as described in the text.
Figure 2. SDS PAGE and coomassie blue staining of samples from se-
lected fermentation time points. Lane M, protein marker, Lane 1 broth 
before inoculation, Lane 2 at inoculation, Lane 3 at 0.2 h fermentation, 
Lane 4 at 3 h, Lane 5 at 6 h, Lane 6 at 8 h, Lane 7 at 22 h.
Figure 4. Colloidal blue stained SDS–PAGE gel apoaequorin for limit of 
detection. Samples of a dilution series of the apoaequorin was loaded 
and separated by SDS–PAGE using a 10 → 20% polyacrylamide tris–
glycine gradient gel. A Bio-Rad Precision Plus marker protein was used 
to estimate MW. Proteins were detected by staining with colloidal bril-
liant blue G stain.
Lane Description                                  Quantity of protein  
                                                                 loaded/well
1 Apoaequorin (300%) 4.41 μg
2 Apoaequorin (200%) 2.94 μg
3 Apoaequorin (175%) 2.57 μg
4 Apoaequorin (150%) 2.21 μg
5 Apoaequorin (125%) 1.84 μg
M Bio-Rad Precision Plus MW Marker na
6 Apoaequorin (100%) 1.47 μg
7 Apoaequorin (80%) 1.18 μg
8 Apoaequorin (60%) 0.88 μg
9 Apoaequorin (50%) 0.74 μg
10 Apoaequorin (40%) 0.59 μg
11 Apoaequorin (20%) 0.29 μg
12 Apoaequorin (10%) 0.15 μg
13 Apoaequorin (5%) 0.07 μg
14 Apoaequorin (2.5%) 0.04 μg
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stability of heterologously expressed proteins using the Turnip Mo-
saic Virus (Chen et al., 2007) and Golgi trafficking of expressed pro-
teins (Luo et al., 2006). Both use the green fluorescent protein of this 
species as a marker, with no indication the protein is an allergen. No 
publications were found using the family name “Aequoridae” with 
“allergen: or “allergy.” Seventy-one publications were identified us-
ing the terms “Cnidaria AND allergy”. Most of the 71 papers de-
scribe allergic reactions to contact with a variety of jellyfish, corals, 
and anemones or treatment of allergic reactions. Only one paper re-
ported identification of the allergenic protein and that (Onizuka et 
al., 2001) was identified by search through the three publications 
identified by “Cnidaria AND allergen”, describing allergy to an aller-
genic protein, of the coral Dendronephthya nipponica.
3.3. In vitro digestion assay
This study evaluated the stability of apoaequorin in two replicate 
assays using pepsin at both pH 1.2 and 2.0. A number of control 
steps were performed to ensure study validity including verify-
ing that the activity of the pepsin at pH 1.2 and 2.0 was within 
the target activity range of 2750 units per mg of solid pepsin, plus 
or minus 23% on each day of assay. Preliminary SDS–PAGE results 
demonstrated that the apoaequorin was as expected in molecu-
lar weight and that the sensitivity of the stained gels and imaging 
system were sufficient to detect the protein from digestion sam-
ples below 10% of the starting material (Figure 4). Specific net in-
tensity values from the Gel Logic 440 image station were plotted in 
a regression (Figure 5) with apparent good fit (r2 = 0.91). Based on 
these data, the limit of detection was approximately 2.5% (0.04 μg) 
of apoaequorin 100% loading (1.47 μg) used in the digestion sam-
ples. This level of sensitivity was clearly sufficient to detect 10% re-
sidual protein in the digest.
The certified activity of the lot of pepsin from Worthington Bio-
chemical used in this study was 2750 units per mg of solid. The ac-
tivity was also verified in the laboratory and was within our quality 
control range. Representative stained gels of replicated digestion 
experiments at pH 1.2 and pH 2.0 demonstrated that apoaequorin 
is stable in acid alone (pH 1.2 or 2) for 60 min (lane 3). It was how-
ever, digested by 0.5 min in pepsin at acidic pH (lane 5) to the ex-
tent that it was less intense than the 10% apoaequorin control in 
quenched pepsin (Figure 6). Thus, the estimated time for 90% di-
gestion was less than 30 s in all digestion experiments. Apoaequo-
rin is therefore considered a rapidly digested protein.
4. Discussion
None of the results from the bioinformatics searches with the 
apoaequorin sequence met the criteria that suggest the protein is 
an allergen or poses a risk of allergenic cross-reactivity or would re-
quire further testing to evaluate potential risks. In addition, the gen-
eral bioinformatics search of NCBI without a keyword limit demon-
strated the protein is highly conserved across a broad range of taxa 
within jellyfish with no obvious published indication of allergy as-
sociated with homologous proteins. Furthermore, searches of pub-
lished literature failed to identify a report, demonstrating allergy to 
A. victoria or other family members, but did identify one publication 
regarding a single protein in a different group within the phylum 
Cnidaria. A number of publications reported allergic or allergic-like 
reactions to various jellyfish, corals, and anemones in this phylum, 
but a paucity of information regarding the proteins implicated in 
sensitization. These results suggest that the entire phylum is not a 
significant cause of allergic reactions in humans.
The proteins that had regions of limited homology that did 
arise in the sequence search of the NCBI protein database were 
calcium-binding proteins and the alignments were in the region 
of calcium binding. This is not surprising since the signature motif 
for calcium-binding proteins is the EF-hand conformation that is 
created by the protein’s helix-loop-helix secondary structure. How-
ever, it is not the primary sequence of the motif that is conserved 
but similar residues (size and charge) that is characteristic of cal-
cium-binding proteins.
Epitope mapping of peptide fragments of calcium-binding pro-
teins of known allergenicity has implicated some residues of an 
EF-hand motif as in the case of parvalbumin; however, the role of 
these residues in the tertiary conformation of the motif and de-
pendence on the presence or absence of bound calcium ion 
(Perez-Gordo et al., 2013) makes extrapolation to globular pro-
teins speculative. In any case, poor sequence alignment of the 
apoaequorin EF-hand domains with the calcium-binding domains 
of other proteins does not support the allergenic potential for 
Table 2. BLASTP of NCBI Entrez “allerg*” with APQ. The scoring alignments of ten best scoring matches with E scores below 10, to putative aller-
gens in the NCBI Entrez database on 20 June, 2010, were compared to the full-length sequence of apoaequorin, using BLASTP.
Sequence GI# Organism Description Length E score % Identity aa alignment
3I7C_A Toxoplasma gondii amoeba Ca+2 dependent protein kinase 484 0.002 27% 90
3I79_A Toxoplasma gondii amoeba Ca+2 dependent protein kinase 484 0.003 27% 90
ABF18354.1 Aedes aegypti mosquito Calmodulin 149 0.01 24% 153
XP_751821.2 Aspergillus fumigates fungus Ca+2 dependent mitochondrial carrier protein 585 0.037 32% 59
BAB86193.1 Oryza sativa rice Putative pollen allergen Jun 0 4 185 0.06 31% 73
AAX77686.1 Ambroxia artemisiifoliashort ragweed Ca+2 bindin protein 160 0.069 24% 157
XP_751821.2 Aspergillus fumigatus fungi Calmodulin 149 0.18 20% 158
O81092.1 Olea europaea rice Polcalcin 84 0.22 33% 51
ADD19708.1 Glossina morsitans fly Calmodulin 149 0.34 22% 150
AAT92161.1 Ixodes pacificus tick Myosin light chain 174 0.39 22% 168
Table 1. Overall FASTA3 search of AllergenOnline version 10.0 with APQ. Four highest scoring alignments of known and putative allergens in Al-
lergenOnline are shown to compare apoaequorin with version 10 of the AllergenOnline.org database using FASTA3.
Sequence GI# Organism Description Length E score % Identity aa alignment
3337403 Olea europaea olive Ca+2 binding protein 84 0.088 33.3 51
131112 Gadus callarias codfish Parvalbumin 113 0.24 35.7 56
77799800 Trachurus japonicus Japanese mackerel Parvalbumin 107 0.37 34.5 55
14531018 Theragra chalcogramma Alaska pollock Parvalbumin 109 0.68 32.7 55
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the protein. Additionally, the ability to predict allergenic epitopes 
based on predicted three-dimensional modeling or other struc-
tural prediction tools has not been demonstrated through valida-
tion to be highly predicted and is thus not recognized as a risk as-
sessment tool for food safety (Goodman and Tetteh, 2011). Instead 
primary sequence comparisons using FASTA (Pearson, 2000) or 
BLASTP (Pearson, 1995) have been demonstrated to be useful for 
identifying proteins that are sufficiently similar in primary structure 
to suspect possible shared IgE binding that might be clinically rel-
evant for allergic consumers (Goodman et al., 2008). Thus, the cri-
teria of the Codex Alimentarius Commission (2003) were followed 
in the bioinformatics analysis used to evaluate potential cross-re-
activity. The results did not identify any significant matches to any 
allergenic protein. This demonstrates that apoaequorin is not ex-
pected to have any significant risk of allergic cross-reactivity for 
those who are allergic to known allergens. In fact, based on these 
Figure 6. Detection of apoaequorin at pH 1.2 (sub-figure A) and pH 2.0 (sub-figure B) with 10,000 pepsin activity units per mg apoaequorin. Diges-
tion products were separated in SDS–PAGE 10–20% gels under reducing conditions. Sample lanes: (m), BioRad# 161-0374 and Invitrogen LC5800 
marker proteins; 1.47 mg of undigested apoaequorin without pepsin (A) at time 0; (B) at time 60 min; (C–J) apoaequorin plus pepsin at times 0, 
0.5, 2, 5, 10, 20, 30, and 60 min of digestion (respectively); K, pepsin alone at time 0; N, pepsin alone at time 60 min; L, undigested apoaequorin 
0.147 μg (10%) at time 0.
Lane Description Incubation time 
M Molecular weight marker Bio-Rad na 
A Apoaequorin control without pepsin (P0) 0 min
B Apoaequorin control without pepsin (P60) 60 min
C Apoaequorin in SGF, (DC) 0 min
D Apoaequorin in SGF, (D0.5) 0.5 min
E Apoaequorin in SGF, (D2) 2 min
F Apoaequorin in SGF, (D5) 5 min
G Apoaequorin in SGF, (D10) 10 min
H Apoaequorin in SGF, (D20) 20 min
I Apoaequorin in SGF, (D30) 30 min
J Apoaequorin in SGF, (D60) 60 min
K Experimental control pepsin (E0) 0 min
L Experimental control pepsin (E60) 60 min
N 10% apoaequorin with quenched pepsin (dC) 0 min
M Molecular weight marker Invitrogen na 
Figure 5. Densitometer readings for the limit of detection of apoaequorin from the colloidal blue stained SDS–PAGE gel (see Figure 1). The Kodak 
Gel Logic 440 with 1D software was used to make the estimation of stainable protein band. Excel was used to calculate the regression and equiv-
alent protein content based on 100% being equal to 1.47 μg per lane. Target apoaequorin amount per lane is 1.47 μg. (A) Lanes 1–14 represent 
30%, 200%, 175%, 150%, 125%, 100%, 80%, 60%, 50%, 40%, 20%, 10%, 5%, 2.5% of the target apoaequorin amount, respectively. (B) Densitometer 
readings for the limit of detection of apoaequorin from the colloidal blue stained SDS–PAGE gel (see sub-Figure A). The Kodak Gel Logic 440 with 
1D software was used to make the estimation of stainable protein band. Excel was used to calculate the regression and equivalent protein content 
based on 100% being equal to 1.47 μg per lane.
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results, it would not be possible to identify allergic individuals who 
would be at a heightened risk by exposure to this protein.
In vitro digestion models are used widely to assess the digest-
ibility of ingested substances. Resistance to digestion is typical of 
allergenic proteins. Based on this study, the rapid digestion char-
acteristics of apoaequorin were similar to those of common non-
allergenic dietary proteins.
From these data, there is no added concern of safety due to 
gastrointestinal stability of the protein.
Disclosures — Dr. R. Goodman reports grants from Quincy Biosci-
ence LLC, during the conduct of the study. Dr. M.Y. Underwood has 
a patent US No. 7,671,015 issued, a patent US Appl. 12/694,427 
pending, and a patent US Appl. 12/672,463 pending. Dr. A. Tetteh 
has nothing to disclose.
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